Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction
Data de publicação:
Autores da FMUP
Participantes de fora da FMUP
- Büttner P.
- Augstein A.
- Abdellatif M.
- Lourenço A.
- Falcão-Pires I.
- Werner S.
- Thiele H.
- Sedej S.
- Schauer A.
- Adams V.
Unidades de investigação
Abstract
Aims: ZSF1 obese rats harbouring two mutant leptin receptor alleles (Leprcp and Leprfa) develop metabolic syndrome and heart failure with preserved ejection fraction (HFpEF), making them a widely used animal model in cardiometabolic research. Studies using ZSF1 rats have contributed significantly to the elucidation of pathophysiological mechanisms underlying HFpEF and therapeutic strategies against this multi-organ syndrome. In contrast, hybrid, lean ZSF1 rats (L-ZSF1) do not develop HFpEF and generally serve as controls, disregarding the possibility that the presence of one mutant Lepr allele might affect left ventricular ejection fraction (LVEF), diastolic dysfunction and other relevant HFpEF parameters, such as N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and cardiac inflammation, which could increase during disease manifestation. Methods and Results: We collected specimens and echocardiography data of male and female L-ZSF1 rats (n = 165; ZSF1-LeprfaLeprcp/Crl) at the age of 6–32 weeks from four independent research groups and performed genotyping as well as the genotype–phenotype analyses. The genotype distribution within L-ZSF1 was in line with the Hardy–Weinberg equilibrium. Genotypes were not associated with CD68 counts (n = 52, P = 0.886), E/e' ratio (n = 125, P > 0.250) and NT-proBNP (n = 126, P = 0.874). LVEF significantly decreased from 25 weeks of age (P = 0.021) but was independent of the genotype (P = 0.768 at <25 weeks of age and P = 0.069 at =25 weeks of age, n = 128). Conclusions: In conclusion, validation of the genotype distribution in L-ZSF1 rats revealed no associations between the genotype and HFpEF-relevant measures, namely, NT-proBNP, CD68 count, LVEF or E/e'. © 2024 The Author(s). ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Dados da publicação
- ISSN/ISSNe:
- 2055-5822, 2055-5822
- Tipo:
- Article
- Páginas:
- -
- DOI:
- 10.1002/ehf2.15111
- PubMed:
- 39663741
- Link para outro recurso:
- www.scopus.com
ESC heart failure The Heart Failure Association of the European Society of Cardiology
Citações Recebidas na Web of Science: 2
Citações Recebidas na Scopus: 2
Documentos
- Não há documentos
Filiações
Keywords
- heart failure with preserved ejection fraction; HFpEF rat model; ZSF1 genotype; ZSF1 rat
Financiamento
Projetos associados
Dapagliflozin, Spironolactone or Both for HFpEF (SOGALDI-PEF) - NCT05676684
Investigador Principal: João Pedro Melo Marques Pinho Ferreira
Ensaio Clínico Académico (SOGALDI-PEF) . AstraZeneca . 2022
The Canadian CABG or PCI in Patients with Ischemic Cardiomyopathy Trial (STICH 3C) - NCT05427370
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Ensaio Clínico Académico (STICH 3C) . Cornell University . 2023
Estudo do tratamento da doença valvular aórtica.
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Observacional Académico (AORTA) . UniC . 2019
Eficácia da transposição de um pedículo adiposo pericárdico sobre o enfarte de miocárdio em pacientes (ensaio AGTP II)
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Ensaio Clínico Académico (Ensaio AGTP II) . 2019
Aortic valve surgery with stented versus stentless bioprosthesis in patients with active infective endocarditis
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Endocarditis) . 2023
Early Dual Antiplatelet Therapy versus Aspirin Monotherapy after Coronary Artery Bypass Surgery: survival and safety outcomes
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Bypass) . 2020
Early and Midterm Outcomes following Aortic Valve Replacement with Mechanical versus Bioprosthetic Valves in Patients aged 50 to 70 Years
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Aortic Valve Replacemen) . 2020
Efeito da terapêutica ß-bloqueadora pré-operatória após cirurgia de revascularização do miocárdio: sobrevida e complicações pós-operatórias
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2021
"Aortic valve surgery in patients with infective endocarditis: mid-term follow-up of patients treated with the St. Jude medical trifecta™ valve"
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2022
Long-term survival after coronary artery bypass grafting: the relevance of surgical procedures analysed by propensity score methods.
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico (Arrtery bypass) . 2022
Abdominal Aortic Aneurysm - The Portuguese Case: Specificities and Consequences
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2022
New Insights into Epidemiology and Pathophysiology of Abdominal Aortic Aneurysms
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2021
Impacto clínico e hemodinâmico da substituição cirúrgica da válvula aórtica por biopróteses de última geração
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2020
Condicionamento isquémico cardíaco remoto como adjuvante da revascularização miocárdia na doença coronário aguda
Investigador Principal: Joaquim Adelino Correia Ferreira Leite Moreira
Estudo Clínico Académico . 2020
Citar a publicação
Büttner P,Augstein A,Abdellatif M,Lourenço A,Leite A,Falcão I,Werner S,Thiele H,Sedej S,Schauer A,Adams V. Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction. ESC Heart Fail. 2024. IF:3,800. (2).
Portal de investigação
